Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 35   Next >
 
1.  
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. 2012 Mar. NGC:009077
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Guideline for the management of bleeding on Dabigatran (Pradaxa). 2012 Feb. NGC:009051
Maine Medical Center, Department of Emergency Medicine - Hospital/Medical Center. View all guidelines by the developer(s)
3.  
Antithrombotic therapy supplement. 2001 Sep (revised 2013 Feb). NGC:009698
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
4.  
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. 2014 Dec. NGC:010622
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Prevention of stroke. In: Canadian best practice recommendations for stroke care. 2006 (revised 2010 Dec 8). NGC:008611
Canadian Stroke Network - Disease Specific Society; Heart and Stroke Foundation of Canada - Disease Specific Society. View all guidelines by the developer(s)
10.  
Prevention of venous thromboembolism. 2004 Mar 6 (revised 2010 Sep 5). NGC:008796
Finnish Medical Society Duodecim - Professional Association. View all guidelines by the developer(s)
12.  
13.  
Venous thromboembolism diagnosis and treatment. 1998 Jun (revised 2013 Jan). NGC:009656
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
14.  
Venous thromboembolism prophylaxis. 2003 Nov (revised 2012 Nov). NGC:009541
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
15.  
Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation. 2012 Jun (revised 2013 Mar). NGC:009802
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
16.  
Knee & leg (acute & chronic). 2003 (revised 2013 Nov 29). NGC:010120
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
17.  
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation. 2013 Feb. NGC:009629
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Atrial fibrillation: the management of atrial fibrillation. 2006 (revised 2014 Jun). NGC:010473
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Guideline on the management of bleeding in patients on antithrombotic agents. 2013 Jan. NGC:009478
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
1-20 of 35   Next >